CIK 0001022899
- Non-accelerated filer
- Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061390025
- Phone
- +1 212-994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- 4 Grant or award Director acquired 11,392 shares (grant or award)
- 4 Grant or award Director acquired 3,892 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 3,892 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 3,892 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 25,000 shares at $1.17 ($29,290)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 25,000 shares at $4.03 ($100,655)
- 4 Other acquisition President acquired 443,085 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 10,000 shares at $4.30 ($42,968)
- 4 Open-market buy 10% owner bought 20,000 shares at an average $4.34 ($86,708)
- 4 Open-market buy 10% owner bought 10,000 shares at $4.21 ($42,071)
- 4 Open-market buy 10% owner bought 70,000 shares at an average $4.28 ($299,751)
Page 5 of 7 · 137 filings